Relationships between obesity, lipids and fasting glucose in the menopause

Srpski Arhiv za Celokupno Lekarstvo

Volumn 141, Issue 1-2, 2013, Pages 41-47

  Netjasov, Aleksandra Simoncig ^a   Vujović, Svetlana ^b   Ivović, Miomira ^b   Tančić Gajić, Milina ^b   Marina, Ljiljana ^b   Barać, Marija ^b  

^a Healthcare Center 'Dr Jovan Jovanovi Zmaj'   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Glucose; Lipids; Menopause; Obesity

Indexed keywords

EID: 84922687077     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1302041S     Document Type: Article

References (36)

1. Milewicz A, Demissie M. Metabolic and endocrine changes in climacteric women. International Congress Series. 2002; 1229: 3-7.
2. McCarthy J. Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. Nutr Metab Cardiovasc Dis. 2006; 17:153-61.
3. Chedraui P. Metabolic changes and the menopause in Ecuador. Maturitas. 2009; 63(Suppl 1):S19.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine. 2006; 23:469-80.
5. Carr M. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 6:2404-11.
6. Stevenson JC. Metabolic profile and cardiovascular system through menopause and ageing: impact on quality of life. Proceedings of 6th IMS Workshop: Menopause and Ageing, Quality of Life and Sexuality; Pisa, Italy, Dec 1-4, 2006; 1-7.
7. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study. Atherosclesrosis. 2006; 189:369-74.
8. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women. Maturitas. 2009; 63:186-90.
9. Chamberlain A, Folsom A, Schreiner P, Boerwinkle E, Ballantyne C. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2008; 200:322-8.
10. Marina Lj, Vujovic S, Penezic Z, Stojanovic M, Ivovic M, Drezgic M. Lipids and women in early and physiological menopause. Maturitas. 2006; 54(Suppl 1):S49.
11. Weinberg M, Manson J, Buring J, Cook N, Seely E, Ridker P, et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 2006; 55:1473-80.
12. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization; 1995.
13. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization; 2000.
14. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63.
15. Ridker P, Buring J, Cook N, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003; 107:391-7.
16. Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas. 2007; 58: 150-5.
17. Rosano G, Vitale C, Fini M. Hypertension in postmenopausal women. European Endocrine Disease. 2006; 1-6.
18. Reckelhoff J, Fortepiani A. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004; 43: 918-23.
19. Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension. 2005; 45:828-33.
20. Alexander C, Landsman P, Grundy S. Metabolic syndrome and hyperglycemia: congruence and divergence. Am J Cardiol. 2006; 7:982-5.
21. Sarraf-Zadegan N, Mohammadifard N. The effect of menopause on the relation between high triglyceride and low HDL-cholesterol with obesity. Atherosclerosis. 2000; 151(1):203.
22. Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiasson I. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab. 2001; 86:744-9.
23. Torng P-L, Su TC, Sung FC, Chien KL, Huang SC, Chow SN, et al. Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis. 2000; 153:413-21.
24. Das U. Obesity, metabolic syndrome X and inflammation. Nutrition. 2002; 5:430-2.
25. Ritchie SA, Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007; 17:319-26.
26. Vujović S. Menopauza. Beograd: Kosmos; 1998.
27. Malacara J, Fajardo M, Nava L. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids. 2001; 66:559-67.
28. Slijepčević D, Vujović S, Nestorović Z. Humana klinička endokrinologija. Beograd: Obeležja; 2002.
29. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-1 and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004; 150:161-71.
30. Mudali S, Dobs A, Ding J, Cauley J, Szklo M, Golden S. Endogenous postmenopausal hormones and serum lipids: the Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab. 2005; 90(2):1202-09.
31. Kalish G, Barrett-Connor E, Laughlin G, Gulanski B. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab. 2003; 88(4):1646-52.
32. Feng Y, Hong X, Wilker E, Li Z, Zhang W, Jin D, et al. Effects of age at menarche, reproductive years and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis. 2008; 196:590-7.
33. Wajchenberg B. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000; 21:697-738.
34. Wahrenberg H, Hertel K, Leijonhufvud B, Persson L, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005; 330:1363-4.
35. Lamon-Fava S, Barnett J, Woods M, McCormack C, McNamara JR, Schaefer EJ, et al. Differences in serum sex hormone and plasma lipid levels in caucasian and African-American premenopausal women. J Clin Endocrinol Metab. 2005; 90(8):4516-20.
36. Genazzani A, Gambacciani M. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol. 2006; 3:145-50.